A citation-based method for searching scientific literature

Elia Sechi, Anastasia Zekeridou. J Thorac Oncol 2021
Times Cited: 7







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
Elia Sechi, Svetomir N Markovic, Andrew McKeon, Divyanshu Dubey, Teerin Liewluck, Vanda A Lennon, A Sebastian Lopez-Chiriboga, Christopher J Klein, Michelle Mauermann, Sean J Pittock,[...]. Neurology 2020
41
42

Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade.
Michel M Sun, Nicolas Seleme, John J Chen, Anastasia Zekeridou, Elia Sechi, Ryan D Walsh, Johanna D Beebe, Osama Sabbagh, Luis J Mejico, Sean Gratton,[...]. J Neuroophthalmol 2021
9
28

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
Douglas B Johnson, Ali Manouchehri, Alexandra M Haugh, Henry T Quach, Justin M Balko, Benedicte Lebrun-Vignes, Andrew Mammen, Javid J Moslehi, Joe-Elie Salem. J Immunother Cancer 2019
138
28

Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: Systematic review.
Annette Johansen, Søren Just Christensen, David Scheie, Joan L S Højgaard, Daniel Kondziella. Neurology 2019
71
28

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
Anastasia Zekeridou, Thomas Kryzer, Yong Guo, Anhar Hassan, Vanda Lennon, Claudia F Lucchinetti, Sean Pittock, Andrew McKeon. Neurology 2019
25
28

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.
Andrew L Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N Donahue, Lauren M Lepone, Anastasia Zekeridou, Sean J Pittock, Raffit Hassan,[...]. Ann Rheum Dis 2019
50
28

Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.
Leila Khoja, Catherine Maurice, MaryAnne Chappell, Leslie MacMillan, Ayman S Al-Habeeb, Nada Al-Faraidy, Marcus O Butler, Patrik Rogalla, Warren Mason, Anthony M Joshua,[...]. Cancer Immunol Res 2016
67
28

Multiple sclerosis outcomes after cancer immunotherapy.
Catherine R Garcia, Rani Jayswal, Val Adams, Lowell B Anthony, John L Villano. Clin Transl Oncol 2019
35
28

Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
Lidia M Yshii, Reinhard Hohlfeld, Roland S Liblau. Nat Rev Neurol 2017
90
28

Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
Tanya J Williams, David R Benavides, Kelly-Ann Patrice, Josep O Dalmau, Alexandre Leon Ribeiro de Ávila, Dung T Le, Evan J Lipson, John C Probasco, Ellen M Mowry. JAMA Neurol 2016
175
28

Central nervous system complications associated with immune checkpoint inhibitors.
Alberto Vogrig, Sergio Muñiz-Castrillo, Bastien Joubert, Geraldine Picard, Veronique Rogemond, Cécile Marchal, Anne Marie Chiappa, Eve Chanson, François Skowron, Amelie Leblanc,[...]. J Neurol Neurosurg Psychiatry 2020
48
28

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.
Alberto Vogrig, Marine Fouret, Bastien Joubert, Géraldine Picard, Véronique Rogemond, Anne-Laurie Pinto, Sergio Muñiz-Castrillo, Maxime Roger, Judith Raimbourg, Charles Dayen,[...]. Neurol Neuroimmunol Neuroinflamm 2019
70
28

Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS.
Samantha A Banks, Padraig P Morris, John J Chen, Sean J Pittock, Elia Sechi, Amy Kunchok, Jan-Mendelt Tillema, James P Fryer, Brian G Weinshenker, Karl N Krecke,[...]. J Neurol Neurosurg Psychiatry 2020
13
28

Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Maciej Jurynczyk, Silvia Messina, Mark R Woodhall, Naheed Raza, Rosie Everett, Adriana Roca-Fernandez, George Tackley, Shahd Hamid, Angela Sheard, Gavin Reynolds,[...]. Brain 2017
317
28

GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
Giorgia Teresa Maniscalco, Sara Mariotto, Romana Höftberger, Ruggero Capra, Giovanna Servillo, Valentino Manzo, Massimo Napolitano, Paolo Candelaresi, Simonetta Gerevini, Sergio Ferrari,[...]. Neurology 2020
6
33

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.
Amy Kunchok, Allen J Aksamit, John M Davis, Orhun H Kantarci, B Mark Keegan, Sean J Pittock, Brian G Weinshenker, Andrew McKeon. JAMA Neurol 2020
39
28


Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.
Elia Sechi, Sara Mariotto, Andrew McKeon, Karl N Krecke, Sean J Pittock, Sergio Ferrari, Salvatore Monaco, Eoin P Flanagan, Serena Zanzoni, Alejandro A Rabinstein,[...]. Stroke 2021
5
40

Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease.
Romina Mariano, Silvia Messina, Kurun Kumar, Wilhelm Kuker, Maria Isabel Leite, Jacqueline Palace. JAMA Netw Open 2019
24
28

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
Elia Sechi, Marina Buciuc, Sean J Pittock, John J Chen, James P Fryer, Sarah M Jenkins, Adrian Budhram, Brian G Weinshenker, A Sebastian Lopez-Chiriboga, Jan-Mendelt Tillema,[...]. JAMA Neurol 2021
30
28

Unfavorable outcome in highly relapsing MOGAD encephalitis.
Marina Buciuc, Elia Sechi, Eoin P Flanagan, A Sebastian Lopez-Chiriboga. J Neurol Sci 2020
6
33

Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.
Elia Sechi, Karl N Krecke, Sean J Pittock, Divyanshu Dubey, A Sebastian Lopez-Chiriboga, Amy Kunchok, Brian G Weinshenker, Nicholas L Zalewski, Eoin P Flanagan. Mult Scler 2021
21
28

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
Divyanshu Dubey, Sean J Pittock, Karl N Krecke, Padraig P Morris, Elia Sechi, Nicholas L Zalewski, Brian G Weinshenker, Eslam Shosha, Claudia F Lucchinetti, James P Fryer,[...]. JAMA Neurol 2019
141
28

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Sven Jarius, Hannah Pellkofer, Nadja Siebert, Mirjam Korporal-Kuhnke, Martin W Hümmert, Marius Ringelstein, Paulus S Rommer, Ilya Ayzenberg, Klemens Ruprecht, Luisa Klotz,[...]. J Neuroinflammation 2020
34
28

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Maciej Jurynczyk, Ruth Geraldes, Fay Probert, Mark R Woodhall, Patrick Waters, George Tackley, Gabriele DeLuca, Saleel Chandratre, Maria I Leite, Angela Vincent,[...]. Brain 2017
146
28

A multicenter comparison of MOG-IgG cell-based assays.
Patrick J Waters, Lars Komorowski, Mark Woodhall, Sabine Lederer, Masoud Majed, Jim Fryer, John Mills, Eoin P Flanagan, Sarosh R Irani, Amy C Kunchok,[...]. Neurology 2019
98
28


A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.
B G Weinshenker, P C O'Brien, T M Petterson, J H Noseworthy, C F Lucchinetti, D W Dodick, A A Pineda, L N Stevens, M Rodriguez. Ann Neurol 1999
507
28

Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.
Maria M Dimitriadou, Haris Alexopoulos, Sofia Akrivou, Eleni Gola, Marinos C Dalakas. Neurotherapeutics 2020
11
28

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Daniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, Santiago Pardo, Matthew Gornall, Silvia Cicconi, Alexander Brandt, Klaus Berek, Thomas Berger, Ilijas Jelcic,[...]. Mult Scler Relat Disord 2020
55
28

Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.
Pierre Durozard, Audrey Rico, Clémence Boutiere, Adil Maarouf, Romaric Lacroix, Sylvie Cointe, Shirley Fritz, Corinne Brunet, Jean Pelletier, Romain Marignier,[...]. Ann Neurol 2020
61
28

Myelin oligodendrocyte glycoprotein antibodies in neurological disease.
Markus Reindl, Patrick Waters. Nat Rev Neurol 2019
230
28

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
S Jarius, F Paul, O Aktas, N Asgari, R C Dale, J de Seze, D Franciotta, K Fujihara, A Jacob, H J Kim,[...]. J Neuroinflammation 2018
343
28

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Dean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, Philippe Cabre, William Carroll, Tanuja Chitnis, Jérôme de Seze, Kazuo Fujihara, Benjamin Greenberg, Anu Jacob,[...]. Neurology 2015
28

Posttransplant autoimmune encephalitis.
Devon A Cohen, A Sebastian Lopez-Chiriboga, Sean J Pittock, Avi Gadoth, Anastasia Zekeridou, Barry A Boilson, William J Hogan, John J Poterucha, Katelynn M Wilton, Yi Lin,[...]. Neurol Neuroimmunol Neuroinflamm 2018
13
28

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Sean J Pittock, Achim Berthele, Kazuo Fujihara, Ho Jin Kim, Michael Levy, Jacqueline Palace, Ichiro Nakashima, Murat Terzi, Natalia Totolyan, Shanthi Viswanathan,[...]. N Engl J Med 2019
300
28

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.
Elia Sechi, Eslam Shosha, Jonathan P Williams, Sean J Pittock, Brian G Weinshenker, B Mark Keegan, Nicholas L Zalewski, Alfonso Sebastian Lopez-Chiriboga, Jiraporn Jitprapaikulsan, Eoin P Flanagan. Neurology 2019
14
28


Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
Hilda Guerra, Sean J Pittock, Kevin G Moder, James P Fryer, Avi Gadoth, Eoin P Flanagan. Mayo Clin Proc 2018
17
28

Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
Sara Mariotto, Alberto Gajofatto, Lucia Batzu, Rachele Delogu, GianPietro Sechi, Stefania Leoni, Maria Immacolata Pirastru, Bruno Bonetti, Mattia Zanoni, Daniela Alberti,[...]. Neurology 2019
47
28

Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder.
Elia Sechi, Marina Buciuc, Eoin P Flanagan, Sean J Pittock, Samantha A Banks, A Sebastian Lopez-Chiriboga, M Tariq Bhatti, John J Chen. Mult Scler Relat Disord 2021
8
28

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Bruce A C Cree, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier,[...]. Lancet 2019
240
28

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
John J Chen, Eoin P Flanagan, Jiraporn Jitprapaikulsan, Alfonso Sebastian S López-Chiriboga, James P Fryer, Jacqueline A Leavitt, Brian G Weinshenker, Andrew McKeon, Jan-Mendelt Tillema, Vanda A Lennon,[...]. Am J Ophthalmol 2018
155
28

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
A Sebastian López-Chiriboga, Masoud Majed, James Fryer, Divyanshu Dubey, Andrew McKeon, Eoin P Flanagan, Jiraporn Jitprapaikulsan, Naga Kothapalli, Jan-Mendelt Tillema, John Chen,[...]. JAMA Neurol 2018
148
28

Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder.
A Sebastian Lopez-Chiriboga, Elia Sechi, Marina Buciuc, John J Chen, Sean J Pittock, Claudia F Lucchinetti, Eoin P Flanagan. JAMA Neurol 2020
26
28

Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings.
Elia Sechi, Alberto Addis, Lucia Batzu, Sara Mariotto, Sergio Ferrari, Maurizio Conti, GianPietro Sechi. Mult Scler 2018
10
28

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W Hümmert,[...]. J Neuroinflammation 2016
478
28

MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.
Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda,[...]. Neurol Neuroimmunol Neuroinflamm 2017
214
28

JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report.
Yasuhiro Oda, Shuku Sato, Emiko Kanbe, Wataru Kamata, Satomi Okada, Yotaro Tamai. Medicine (Baltimore) 2019
3
33

Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate.
Mario Ojeda-Uribe, Sylvain Merieau, Marie Guillon, Olivier Aujoulat, Olivier Hinschberger, Jean-Claude Eisenmann, David Kenizou, Agathe Debliquis, Agnès Veyradier, François Chantrel. J Oncol Pharm Pract 2016
8
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.